1[1]Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, Pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J. 1990,66 (Suppl4):S 18-21 被引量：1
2[2]Olkkola KT, Brunetto AV, Mattila MJ. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharmacokinet, 1994, 26:107-120 被引量：1
3[3]Kullich W, Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam in on the secretion of the endogenous opiate peptides dynorphin and β-endorphin. Aktuel Rheumatol, 1992, 17:128-132 被引量：1
4[4]Detlef ER, Morten A, Dietmar S. A comparison of patientcontrolled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth Analg. 1998,86:1045-1050 被引量：1
5[5]Ilias W, Jansen M. Pain control after hysterectomy: an observer-blind, randomised trial of lornoxicam versus tramadol.Br J Clin Pract, 1996, 50:197-202 被引量：1
7[7]Berg J, Christoph T, Widerna M, et al. Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6. J Pharmacol Toxicol Methods, 1997, 37;179-186 被引量：1
8[8]Nuutinen LS, Laitinen JO, Salomaki TE. A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain. Drug Safety, 1993, 9:380-393 被引量：1
9[9]Ilder-Smith CH, Bettiga A. The analgesic tramadol has minimal effect on gastrointestinal motor function. Br J Clin Pharmacol, 1997,43:71 被引量：1
10Pruss TP, Stroissnig H, Radhofer Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lomoxicam[ J ]. Postgrad Med J, 1990, 66 (Suppl 4):S18 - S21. 被引量：1
